Catalog Research
CatalogAnabolic › IGF-1 LR3 1mg
Anabolic

IGF-1 LR3 1mg

IGF-1 LR3 1mg — research compound vial

An extended-acting analogue of a naturally occurring growth factor, engineered for a 20-30 hour research window. One of the most referenced compounds in laboratory studies of muscle cell development and signaling.

1mg
$66

How It Works

The Target

IGF-1 receptors throughout the body, particularly in skeletal muscle. LR3 is a modified version of natural IGF-1 with two key engineering changes.

The Mechanism

The modifications (Arg3 substitution + 13-amino acid extension) dramatically reduce binding to IGF binding proteins, which normally sequester and deactivate IGF-1. This means LR3 stays active 20-30 hours vs 20 minutes for native IGF-1. It activates the PI3K/Akt/mTOR pathway — the primary signaling cascade for protein synthesis.

Why It Matters

The extended activity window and reduced binding protein interference make LR3 one of the most studied compounds in muscle cell development and regeneration research.

Specifications

Purity>=98%
MW~9.1 kDa
FormLyophilized white powder
Storage-20 degrees C
ReconstitutionAcetic acid 0.1% / PBS
Shelf Life24 months

Published References

review
Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan (Drug design, development and therapy 2024) ↗
review
Novel therapies for growth disorders (European journal of pediatrics 2024) ↗
review
Long-acting growth hormone in the management of GHD in France (Archives de pediatrie : organe offici... 2024) ↗

IGF-1 LR3 1mg

Third-party verified · batch COAs · US-based fulfillment

View in Catalog →
Research Use Only. IGF-1 LR3 1mg is sold exclusively for in vitro laboratory research. It is not a drug, dietary supplement, food, or medical device, and has not been evaluated by the FDA for any purpose. Not for human or veterinary use. NST Research makes no therapeutic, diagnostic, or health claims regarding any compound listed.